Gregg W. Stone, MD, FACC, FSCAI

Our colleague and cath lab expert, Dr. Barry Uretsky from the University of Arkansas, Little Rock, started this conversation with one of the oldest and probably most important questions about coronary angiography, and that is, how should we...

Our colleague and cath lab...

01/06/2016

Cath Lab Digest

Why Is My Lab’s PCI Volume Decreasing?

11/05/2012

John Bittl , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

James E. Tcheng , MD;

Mladen I. Vidovich , MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Peter Ver Lee , MD;

Michael J. Lim , MD;

John W. Hirshfeld Jr.;

Samuel M. Butman , MD;

Aaron V. Kaplan ;

Gregory J. Dehmer , MD;

Carl L. Tommaso , MD;

Kirk N. Garratt , MD, MSc;

Ted A. Bass , MD;

Lloyd W. Klein , MD;

In this “Conversation in Cardiology,” Dr. Carl Tommaso asks, “Since 2006, the number of percutaneous coronary interventions in the United States is down 39% (963,000 procedures in 2006, 589,000 in 2010), with an estimated 10-15% decrease in...

In this “Conversation in...

11/05/2012

Cath Lab Digest

Original Contribution

Classification for Assessing the Quality of Diagnostic Coronary Angiography

08/15/2017

Martin B. Leon , MD;

Nicolas Bettinger , MD;

Philippe Généreux , MD;

Roxana Mehran , MD;

Gregg W. Stone , MD, FACC, FSCAI;

In the present report, we sought to establish a novel standardized quantitative classification for the quality of coronary angiography, taking into consideration two main parameters: coronary contrast filling and coronary sinus contrast...

In the present report, we sought...

08/15/2017

Journal of Invasive Cardiology

Case Series

Successful Surgical Treatment of Severe Calciphylaxis Using a Bilayer Dermal Replacement Matrix

11/11/2015

Soyun M. Hwang ;

Joseph N. Carey ;

Justin Gillenwater ;

Gregg W. Stone , MD, FACC, FSCAI;

Dipesh Solanky ;

11/11/2015

Wounds

Clinical Editor's Corner

To PRAMI or not to PRAMI: Should we do PCI of the Non-Infarct-Related Artery in STEMI Patients?

01/07/2014

Gregg W. Stone , MD, FACC, FSCAI;

Michael A. Kutcher , MD, FACC, FSCAI;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Habib Samady , MD;

Justin E. Davies , MBBS, MRCP, PhD;

Peter Ver Lee , MD;

John Bittl , MD;

Samuel M. Butman , MD;

Lloyd W. Klein , MD;

My cardiology fellow said we should now stent the RCA since we were already here and the patient was quite stable. I demurred and said we will be back in a couple weeks unless the patient develops angina. The RCA could be treated after...

My cardiology fellow said we...

01/07/2014

Cath Lab Digest

INFUSE-AMI: Intracoronary Abciximab in STEMI Patients

05/02/2012

Gregg W. Stone , MD, FACC, FSCAI;

The INFUSE-AMI [Intracoronary Abciximab Infusion and Aspiration Thrombectomy in Patients Undergoing Percutaneous Coronary Intervention for Anterior ST Segment Elevation Myocardial Infarction (MI)] trial, a prospective, randomized,...

The INFUSE-AMI [Intracoronary...

05/02/2012

Cath Lab Digest

Original Contribution

Revascularization Strategies for Calcified Lesions in Patients Presenting With Acute Coronary Syndromes (From the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] Trial)

12/29/2015

Giora Weisz , MD;

Rupa Parvataneni , MS;

Gregg W. Stone , MD, FACC, FSCAI;

Madhudhan Tarigopula , MD, MPH;

Mahesh V. Madhavan , MD;

Philippe Généreux , MD;

Roxana Mehran , MD;

An investigation of the optimal revascularization strategy for calcified lesions in patients presenting with NSTEACS.

An investigation of the optimal...

12/29/2015

Journal of Invasive Cardiology

Original Contribution

Treatment of Restenotic Drug-Eluting Stents: An Intravascular
Ultrasound Analysis

08/01/2008

Koichi Sano , MD, PhD;

Stephane G. Carlier , MD, PhD;

Emilia Solinas , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Jie Qian , MD;

Gary S. Mintz , MD;

Eduardo Missel , MD;

Martin B. Leon , MD;

Roxana Mehran , MD;

Shoujie Shan , MD;

Alexandra J. Lansky , MD;

Jeffrey W. Moses , MD;

Theresa Franklin-Bond , MS, PA;

George D. Dangas , MD, PhD;

Giora Weisz , MD;

Paul Boland , BS;

Michael B. Collins , MD;

Nobuhiko Fujita , MD;

Edward M. Kreps , MD;

Issam Moussa , MD;

Jose de Ribamar Costa Jr., MD, PhD;

Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...

Sirolimus-eluting and...

08/01/2008

Journal of Invasive Cardiology

Clinical Editor's Corner

Conversations in Cardiology: The End of End-hole Left Ventriculography – A Consensus of Operators

11/14/2013

Joseph D. Babb , MD;

George W. Vetrovec , MD;

John Bittl , MD;

Lloyd W. Klein , MD;

Allen Jeremias , MD, MSc;

Gregg W. Stone , MD, FACC, FSCAI;

Steven R. Bailey , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Frederick G.P. Welt , MD;

David G. Rizik , MD, FACC, FSCAI;

Mladen I. Vidovich , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Charles E. Chambers , MD;

Christopher J. White , DO, MD;

Barry F. Uretsky , MD;

Peter Ver Lee , MD;

Mitchell W. Krucoff , MD;

Bernard DeBruyne ;

Kirk N. Garrett ;

Carl L. Tommaso , MD;

Malcolm R. Bell , MD;

Left ventriculography, once an integral part of every cardiac angiographic procedure, has been reconsidered as often unnecessary in light of high quality echocardiography for left ventricular (LV) functional assessment.

Left ventriculography, once an...

11/14/2013

Cath Lab Digest

The ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) Trial: What`s the Next Step for Bivalirudin After R

06/19/2008

Gregg W. Stone , MD, FACC, FSCAI;

What is the basic study strategy behind the ACUITY trial? ACUITY will enroll 13,800 patients with moderate-to-high unstable angina, all of whom are intended to undergo an invasive strategy. These patients will usually be in the cath lab...

What is the basic study strategy...

06/19/2008

Cath Lab Digest